Delivering value through Insights that matter!

Home / Report / Healthcare / Biotechnology / Global Ovarian Cancer Diagnostics and Therapeutics Market

Global Ovarian Cancer Diagnostics and Therapeutics Market Sizes and Trends

Global Ovarian Cancer Diagnostics and Therapeutics Market

$3,850.0 – $7,700.0

Industry Analysis, Forecasts and Opportunity Assessment (2017-2022)

  • Market Trends, Dynamics and Regulatory Framework
  • Regional and Cross-segment Sales Figures
  • Extensive Industry Structure Coverage

Sample Report Request Customisation

Clear
SKU: N/A Category:

Description

An uncontrollable cell growth in the ovarian tissue causes ovarian cancer. It is one of the leading causes of death in women and hence is a growing concern across the globe. Hence, there is an increasing need to develop new medicines and therapies for its treatment along with the invention of new methods for the timely or early diagnosis of this cancer. Thus, the global market for ovarian cancer diagnostics and therapeutics shows immense potential for growth and development.

Market Dynamics

The global ovarian cancer diagnostics and therapeutics market accounted for more than USD 1100 million in 2015 and is expected to grow at a CAGR of around 10-16% during the forecast period. Following are the driving and restraining factors for this market:

Drivers:

• Increasing incidences of ovarian cancer worldwide
• Increasing population of aged women
• Increase in healthcare expenditure
• Increased government funding
• Increasing healthcare awareness
• Greater use of combination therapies for the treatment

Restraints:

• Launch of generic drugs
• Patent expiry of key drugs
• Lack of accurate diagnosis of ovarian cancer

Market Segmentation

Segmentation on the basis of type:
• Epithelial ovarian tumours
• Ovarian germ cell tumours
• Ovarian stromal tumours
• Primary peritoneal carcinoma

Segmentation on the basis of cancer stage:
• Stage I
• Stage II
• Stage III
• Stage IV

Segmentation on the basis of diagnosis:

• Physical examination
• Biopsy
• Blood tests
• Human Chorionic Gonadotropin (HCG) test
• Ultrasound
• MRI
• PET
• CT Scans

Segmentation on the basis of treatment:
• Chemotherapy
• Targeted therapy
• Immunotherapy
• Hormonal therapy
• Surgery

Segmentation on the basis of geography:
• North America
• Europe
• Asia-Pacific
• Middle East & Africa
• South America

Opportunities

The global ovarian cancer diagnostics and therapeutics market is dominated by North America while Europe has the second largest market share. However, the Asia-Pacific region is anticipated to grow at comparatively higher rates during the forecast period owing to the increasing number of aging population and high prevalence of ovarian cancer. Countries such as China and India are expected to be the fastest growing markets for ovarian cancer diagnostics and therapeutics in the Asia-Pacific region.

Key Players

• Bristol Myers Squibb Company
• Eli Lilly and Company
• GlaxoSmithKline Plc
• Janssen Pharmaceuticals
• Genentech Inc.
• Astra Zeneca
• Boehringer Ingelheim GmbH
• Hoffmann La Roche Ltd.

Report ContentsRegional AnalysisReport Highlights
  • Market segments
  • Market Drivers, Restraints and Opportunities
  • Market Size & Forecast 2016 to 2022
  • Supply & Demand Value Chain
  • Market – Current Trends
  • Competition & Major Companies
  • Technology and R&D Status
  • Porters Five Force Analysis
  • Strategic and Critical Success Factor Analysis of Key Players
  • North America
    • US and Canada
  • Latin America
    • Mexico, Brazil, Argentina and Rest of Latin America
  • Western Europe
    • EU5 (Germany, France, Italy, Spain, U.K.)
    • Nordic Countries (Denmark, Finland, Norway, and Sweden)
    • Benelux (Belgium, The Netherlands, and Luxembourg)
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Rest of Eastern Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia and New Zealand
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
    • South Africa
    • North Africa
    • Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

  • Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
  • Consumer and Pricing Analysis
  • Market dynamics of the industry
  • Market Segmentation
  • Estimated Market Sizing in terms of volume and value
  • Recent trends in Market and impact
  • Research Status and Technology Overview
  • Extensive Industry Structure Coverage

 

Related Products:

Global Ovarian Cancer Diagnostics and Therapeutics Market

Introduction Cancer is one of the prime fatal disease in the world. Its prevalence is increasingly found. This has forced advanced treatment techniques for this disease. Development of effective diagnostic tool are on high demand. Cancer can be treated more efficiently if detected at the early stage. Routine check-up is promoted by healthcare professional to identify the cancer in the early stages. Market Dynamics Global Cancer Diagnostic Market faces a great growth due to factor lik...

Global Ovarian Cancer Diagnostics and Therapeutics Market

The Global Cancer Therapies Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Cancer occurs due to the uncontrolled growth of certain type of cells in the body. If untreated, this abnormality can spread to other areas of the body. Cancer is the second largest cause of death across the globe. The novel approaches and personalised medicine development are providing an upgrade to the existing global cance...

Global Ovarian Cancer Diagnostics and Therapeutics Market

The Global Cancer Biomarkers Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Biomarkers are chemical, physical or biological parameters used for cancer detection. They are produced by either the cancerous cell or by some other cell in response to cancer. They form one of the most non-invasive and high-speed cancer detection techniques. Biomarkers facilitate a plethora of applications such as cancer d...

Global Ovarian Cancer Diagnostics and Therapeutics Market

The Global Breast Cancer Screening TestsMarket is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Breast cancer is a global problem affecting both developed and developing countries. It is considered to be the cause of approximately 60% of the deaths in developing countries. The risk factors that contribute to its widespread occurrence are mainly age and family history. Despite advancements in medicine, breast...

Global Ovarian Cancer Diagnostics and Therapeutics Market

The Global Colorectal Cancer Screening Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Cancer occurs due to the uncontrolled growth of certain type of cells in the body. If untreated, this abnormality can spread to other areas of the body. Colorectal cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death in both men and women in the US. The symptoms of colorect...

Global Ovarian Cancer Diagnostics and Therapeutics Market

The occurrence of kidney cancer has increased in the recent years. Excessive smoking, rise in obesity because of sedentary life routines and increased consumption of alcohol are some of the causes of kidney cancer. The most common type of cancer is Renal Cell Carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma. Almost 9 out of 10 kidney cancers are renal cell carcinomas. Another type of kidney cancer present among a few individuals is transitional cell carcinoma (TCC...

Global Ovarian Cancer Diagnostics and Therapeutics Market

The global liver cancer market is projected to reach USD X billion in 2022, up from about USD X billion in 2017, growing at a CAGR of X% during the forecast period 2017-2022. The global liver cancer market has seen tremendous growth over the past few years due to rising incidences of liver cancer in the population. While excessive alcohol and narcotics consumption can be blamed for this rise, it is also attributed to the prevalence of unhealthy lifestyle choices among the people. Since the dr...

Global Ovarian Cancer Diagnostics and Therapeutics Market

Introduction In today's world, with the growing urbanization, pollution, especially air pollution is also increasing at an alarming rate as evident from some of the world’s major cities. This is a major contributor to the increasing prevalence of lung cancer which is giving rise to the global lung cancer surgery market. Today, the lung cancer surgery market consists of numerous types of surgeries and also, there is active research towards increasing automation to make the surgeries more ef...

Global Ovarian Cancer Diagnostics and Therapeutics Market

In today's world, with the growing urbanization, air pollution is one of the major reasons for concern regarding people's health concerns. One of the major diseases that is getting prevalence, mostly among the developed countries is lung cancer. This is giving rise to the therapeutics market for lung cancer. Also, the developing markets are having increasing concerns about this disease and therefore, the therapeutics market is expected to develop rapidly. End-User/Technology The end-use...

Global Ovarian Cancer Diagnostics and Therapeutics Market

An uncontrollable cell growth in the ovarian tissue causes ovarian cancer. It is one of the leading causes of death in women and hence is a growing concern across the globe. Hence, there is an increasing need to develop new medicines and therapies for its treatment along with the invention of new methods for the timely or early diagnosis of this cancer. Thus, the global market for ovarian cancer diagnostics and therapeutics shows immense potential for growth and development. Market Dynamic...

Global Ovarian Cancer Diagnostics and Therapeutics Market

The uncontrolled growth of cells in the pancreas causes pancreatic cancer. It is an abnormal, unrestrained growth of cells which leads to formation of lumps in the tissues, usually referred to as tumors. These tumors prevent the normal functioning of the pancreas. According to SEER, around 7% of the total cancer deaths is accounted by pancreatic cancer. Its occurrence and mortality rate is comparatively high in men than in women. Smoking is the biggest risk factor leading to pancreatic cancer...

Related products

×
Sample Report
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. You may contact us at any time to opt-out. Please tick here to receive these communications.
×
Report Customisation
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. You may contact us at any time to opt-out. Please tick here to receive these communications.
×
Services Contact
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. You may contact us at any time to opt-out. Please tick here to receive these communications.
×